pd 173074 and chir 258
pd 173074 has been researched along with chir 258 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Cheng, W; Tian, X; Wang, M; Zhang, X | 1 |
| Dubiel, K; Dzwonek, K; Hucz-Kalitowska, J; Lamparska-Przybysz, M; Lipner, J; Magdycz, M; Olejkowska, P; Pieczykolan, J; Piórkowska, N; Popiel, D; Stańczak, A; Stańczak, PS; Wieczorek, M; Yamani, A; Zdżalik-Bielecka, D | 1 |
Reviews
2 review(s) available for pd 173074 and chir 258
| Article | Year |
|---|---|
An overview of the binding models of FGFR tyrosine kinases in complex with small molecule inhibitors.
Topics: Humans; Protein Binding; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Small Molecule Libraries | 2017 |
Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1-3).
Topics: Antineoplastic Agents; Benzimidazoles; Cell Proliferation; Drug Discovery; Humans; Protein Kinase Inhibitors; Pyrazoles; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3 | 2021 |
Other Studies
1 other study(ies) available for pd 173074 and chir 258
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |